STK33 and cancer: Accumulating evidence confirms that elevated STK33 expression correlates with poor prognosis in cancer patients, making it a valuable marker for clinical diagnosis and prognosis.[20, 33] Here, we demonstrate, for the first time, that STK33 is upregulated in TNBC and predicts poor prognosis.